Chromatin/Epigenetics
Chromatin/Epigenetics(染色质/表观遗传学)
Epigenetics
Epigenetics means above genetics. It determines how much and whether a gene is expressed without changing DNA sequences. Epigenetic regulations include, 1. DNA methylation: the addition of methyl group to DNA, converting cytosine to 5-methylcytosine, mostly at CpG sites; 2. Histone modifications: posttranslational modificationEpigeneticss of histone proteins including acetylation, methylation, ubiquitylation, phosphorylation and sumoylation; 3. miRNAs: non-coding microRNA downregulating gene expression; 4. Prions: infectious proteins viewed as epigenetic agents capable of inducing a phenotype without changing the genome.
- Bromodomain(50)
- Aurora Kinase(63)
- DNA Methyltransferase(35)
- HDAC(210)
- Histone Acetyltransferases(78)
- Histone Demethylases(110)
- Histone Methyltransferase(240)
- HIF(102)
- JAK(173)
- MBT Domains(1)
- PARP(122)
- Pim(32)
- Protein Ser/Thr Phosphatases(34)
- RNA Polymerase(7)
- Sirtuin(77)
- Sphingosine Kinase-2(1)
- Polycomb repressive complex(2)
- SUMOylation(3)
- PAD(21)
- Epigenetic Reader Domain(246)
- MicroRNA(24)
- Protein Arginine Deiminase(7)
- Chromodomain(1)
- Citrullination(20)
- DNA/RNA Demethylation(2)
- DNA/RNA Methylation(8)
- Histone Deacetylation(44)
- Histones/Histone Peptides(62)
- PHD Domains(1)
- Tandem Tudor & Tudor-like Domains(1)
- PRMT(2)
- Readers(1)
- Small Interfering RNA (siRNA)(1)
- METTL3(2)
- WDR5(1)
- TET Protein(2)
- HuR(1)
- SF3B1(1)
Chromatin/Epigenetics 相关产品(1617)
- GC11525Pyridone 6CAS: 457081-03-7纯度: >98.50%
吡啶酮 6 抑制 Jak3,K(I)=5 nM; Pyridone 6 还抑制 Jak 家族成员 Tyk2 和 Jak2,IC(50)=1 nM 和 Jak1,IC(50)=15 nM。
- GC16828Tofacitinib (CP-690550,Tasocitinib)CAS: 477600-75-2纯度: >98.00%
Tofacitinib (CP-690550,Tasocitinib)是一种Janus激酶(JAK)抑制剂,用于治疗类风湿关节炎、银屑病关节炎、强直性脊柱炎、多关节病程青少年特发性关节炎和溃疡性结肠炎。
- GC17020S-Ruxolitinib (INCB018424)CAS: 941685-37-6纯度: >99.50%
鲁索替尼 S 对映体是鲁索替尼的 S 对映体。鲁索替尼 S 对映异构体是一种 JAK 抑制剂
- GC170551,2,3,4,5,6-HexabromocyclohexaneCAS: 1837-91-8
1,2,3,4,5,6-六溴环己烷(1,2,3,4,5,6-Hexabromocyclohexane)直接抑制JAK2激酶结构域内的口袋,抑制自身磷酸化。
- GC13347Cucurbitacin ICAS: 2222-07-3纯度: >98.00%
Cucurbitacin I是一种选择性的Janus激酶(JAK)/STAT3信号通路抑制剂,在A549细胞中的IC 50 值为500nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC14945 | Sirtinol | 410536-97-9 | >98.00% | |
Inhibitor of sirtuin deacetylases | ||||
| GC15259 | EPZ004777 HCl | 1380316-03-9 | >98.00% | |
EPZ004777 HCl 是一种有效的选择性 DOT1L 抑制剂,IC50 为 0.4 nM。 | ||||
| GC16468 | CYT387 sulfate salt | 1056636-06-6 | >98.00% | |
A potent inhibitor of JAK1 and JAK2 | ||||
| GC17178 | TCS PIM-1 1 | 491871-58-0 | >98.00% | |
A Pim-1 kinase inhibitor | ||||
| GC10617 | GSK J1 | 1373422-53-7 | >99.50% | |
A dual inhibitor of JMJD3 and UTX | ||||
| GC15956 | WHI-P97 | 211555-05-4 | >99.00% | |
WHI-P97 是一种有效的选择性 JAK-3 抑制剂。 | ||||
| GC15965 | MC1568 | 852475-26-4 | - | |
A selective class IIa HDAC inhibitor | ||||
| GC11525 | Pyridone 6 | 457081-03-7 | >98.50% | |
吡啶酮 6 抑制 Jak3,K(I)=5 nM; Pyridone 6 还抑制 Jak 家族成员 Tyk2 和 Jak2,IC(50)=1 nM 和 Jak1,IC(50)=15 nM。 | ||||
| GC10479 | PHA-680632 | 398493-79-3 | >99.50% | |
An Aurora kinase inhibitor | ||||
| GC13229 | NVP-BSK805 | 1092499-93-8 | - | |
A potent, selective JAK2 inhibitor | ||||
| GC16124 | Ruxolitinib phosphate | 1092939-17-7 | >99.50% | |
A potent and selective JAK1/JAK2 inhibitor | ||||
| GC16828 | Tofacitinib (CP-690550,Tasocitinib) | 477600-75-2 | >98.00% | |
Tofacitinib (CP-690550,Tasocitinib)是一种Janus激酶(JAK)抑制剂,用于治疗类风湿关节炎、银屑病关节炎、强直性脊柱炎、多关节病程青少年特发性关节炎和溃疡性结肠炎。 | ||||
| GC17020 | S-Ruxolitinib (INCB018424) | 941685-37-6 | >99.50% | |
鲁索替尼 S 对映体是鲁索替尼的 S 对映体。鲁索替尼 S 对映异构体是一种 JAK 抑制剂 | ||||
| GC14327 | XL019 | 945755-56-6 | >98.00% | |
A potent, bioavailable JAK2 inhibitor | ||||
| GC12064 | SB1317 | 937270-47-8 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC17055 | 1,2,3,4,5,6-Hexabromocyclohexane | 1837-91-8 | - | |
1,2,3,4,5,6-六溴环己烷(1,2,3,4,5,6-Hexabromocyclohexane)直接抑制JAK2激酶结构域内的口袋,抑制自身磷酸化。 | ||||
| GC15391 | Cercosporamide | 131436-22-1 | - | |
A potent inhibitor of fungal Pkc1 and mammalian Mnk isoforms | ||||
| GC13347 | Cucurbitacin I | 2222-07-3 | >98.00% | |
Cucurbitacin I是一种选择性的Janus激酶(JAK)/STAT3信号通路抑制剂,在A549细胞中的IC 50 值为500nM。 | ||||
| GC14590 | AR-42 (OSU-HDAC42) | 935881-37-1 | - | |
HDAC inhibitor,novel and potent | ||||
| GC14671 | JANEX-1 | 202475-60-3 | >98.00% | |
A selective JAK3 inhibitor | ||||
| GC12118 | SD 1008 | 960201-81-4 | - | |
SD 1008 是一种有效的 JAK 抑制剂。 SD 1008 抑制 STAT3、JAK2 和 Src 的酪氨酰磷酸化。 SD 1008 还降低 STAT3 依赖性荧光素酶活性。 SD 1008 通过直接阻断 JAK-STAT3 信号通路增强紫杉醇诱导的卵巢癌细胞凋亡。 | ||||
| GC15536 | NCH 51 | 848354-66-5 | >99.50% | |
An HDAC inhibitor | ||||
| GC15040 | NSC 3852 | 3565-26-2 | - | |
A tumor cell differentiating agent | ||||
| GC16584 | TCS 21311 | 1260181-14-3 | >95.00% | |
A JAK3 inhibitor | ||||
